- Home
- NOTV vs NSPR Comparison
NOTV vs NSPR Comparison
Compare NOTV & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NOTV
- NSPR
- Stock Information
- Founded
- NOTV 1974
- NSPR 2005
- Country
- NOTV United States
- NSPR United States
- Employees
- NOTV N/A
- NSPR N/A
- Industry
- NOTV Biotechnology: Pharmaceutical Preparations
- NSPR Medical/Dental Instruments
- Sector
- NOTV Health Care
- NSPR Health Care
- Exchange
- NOTV Nasdaq
- NSPR Nasdaq
- Market Cap
- NOTV 57.7M
- NSPR 74.8M
- IPO Year
- NOTV 1997
- NSPR N/A
- Fundamental
- Price
- NOTV $1.69
- NSPR $2.44
- Analyst Decision
- NOTV Strong Buy
- NSPR Strong Buy
- Analyst Count
- NOTV 1
- NSPR 2
- Target Price
- NOTV $5.00
- NSPR $4.50
- AVG Volume (30 Days)
- NOTV 429.6K
- NSPR 104.0K
- Earning Date
- NOTV 08-06-2025
- NSPR 08-05-2025
- Dividend Yield
- NOTV N/A
- NSPR N/A
- EPS Growth
- NOTV N/A
- NSPR N/A
- EPS
- NOTV N/A
- NSPR N/A
- Revenue
- NOTV $505,299,000.00
- NSPR $7,066,000.00
- Revenue This Year
- NOTV $5.64
- NSPR $7.48
- Revenue Next Year
- NOTV $5.16
- NSPR $104.39
- P/E Ratio
- NOTV N/A
- NSPR N/A
- Revenue Growth
- NOTV 0.85
- NSPR 7.60
- 52 Week Low
- NOTV $1.15
- NSPR $1.99
- 52 Week High
- NOTV $6.48
- NSPR $3.80
- Technical
- Relative Strength Index (RSI)
- NOTV 41.79
- NSPR 49.20
- Support Level
- NOTV $1.65
- NSPR $2.36
- Resistance Level
- NOTV $1.85
- NSPR $2.49
- Average True Range (ATR)
- NOTV 0.13
- NSPR 0.11
- MACD
- NOTV -0.01
- NSPR -0.01
- Stochastic Oscillator
- NOTV 8.33
- NSPR 40.00
About NOTV Inotiv Inc.
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.